Press Release EU ZA

Master Plant Awarded Cannabis Licence In Guernsey

Published

7 months ago

February 23, 2023

admin

PRESS RELEASE

MASTER Plant Holdings (“Master Plant”), an emerging player in the European cannabis industry, have been awarded a cannabis licence for research, development and manufacturing on the island of Guernsey.

The licence, only the second issued by the Bailiwick of Guernsey, represents a major milestone for Master Plant and the UK cannabis industry. The company are now among a small handful of businesses in the UK and British Isles to be awarded the cannabis licence.

Master Plant is well placed to capitalise on the burgeoning legal cannabis market in Europe, estimated to be valued at $13.4bn by 2027 by Market Data Forecasts. Master Plant has consolidated decades of research and development into its proprietary cannabis genetics bank, which provides diversity in major and minor cannabinoids, as well as other beneficial molecules that will contribute to a vast assortment of future products.

Master Plant Chairman and industry veteran, Len Werden, said, “Our legacy strains, with years of innovation and market penetration on the clock, give a substantial platform for launching premium products and developing further strains. It’s really encouraging to see investors focusing on genetics and quality these days. This is what the industry has traditionally taken pride in, rather than the huge projects that have frequently failed in recent years.”

Master Plant intends to retrofit its 60,000 sqft greenhouse in Guernsey to build a world class cultivation and manufacturing facility with the intent of serving the legal cannabis market. The company will continue to focus on the further development of its genetics portfolio and the creation of highly controlled single-serve products, alongside its manufacturing, brand, and distribution capabilities.

CTO Phil Petelski, an industry veteran who has licenced and built eleven cannabis facilities in North America, said, “This is meaningful step for Master Plant and its investors. We would like to thank the Bailiwick of Guernsey Cannabis Agency and all parties that have supported us thus far. The European cannabis industry is full of promise and with our team’s extensive knowledge and experience from the North American markets, we have a great opportunity to create a major European entity with solid fundamentals.”

Master Plant, upon completion of investment, will begin the retrofit of its facility in Q2 of 2023, with a targeted completion date for early 2024.

About Master Plant

Master Plant is blazing the trail in the legal adult-use cannabis market. This market exists today thanks to medical and low THC products across Europe. Master Plant is building brands and products to meet today’s legal requirements with an eye on unlocking the future potential of full-strength THC. Master Plant’s goal is to improve well-being across generations with life-enhancing products.

Source link

Press Release EU ZA

Press Release: Lyphe Group and Boveda INC. Forge Partnership for UK Medical Cannabis Patients

Published

2 weeks ago

September 14, 2023

admin

Lyphe Group (“Lyphe”), one of the UK’s leading medical cannabis companies, is pleased to announce an innovative partnership set to enhance the way patients receive their medical cannabis prescriptions.

In an industry first, Lyphe’s dispensing pharmacy Dispensary Green has partnered with Boveda Inc. (“Boveda”), the global leader in 2-way humidity control, to empower patients to keep their cannabis prescriptions in optimal condition.

As part of the partnership, Dispensary Green will include complimentary Boveda packs with all medical cannabis flower prescriptions. Dispensary Green and Boveda will also work together to educate patients on how to preserve the freshness of their medication and identify key quality markers.

Nick Pateras, CEO of Lyphe Group, said: “This partnership exemplifies our commitment to supporting patients’ rights for the highest quality medical cannabis.

“Our ambition to deliver a best-in-class patient experience has led us to identify several opportunities for standout patient care, and our relationship with Boveda is the first of these initiatives. We understand the importance of patients’ medicine being at its freshest and most effective for the conditions they are treating.”

Benjamin Patock, Head of International Relations at Boveda Inc., adds: “Proper humidification is one of the most pressing global challenges in cannabis care today, especially since it extends beyond the point of sale into patients’ homes – and therefore beyond the direct control of producers, clinics, and pharmacies.

“It is a pleasure to see medicinal pioneers such as Lyphe Group taking this extra step towards a flawless patient experience by embracing our patented technology. We are looking forward to a great partnership!”

Source link

Press Release EU ZA

ElixinolSkin cosmetics return to UK

Published

6 months ago

April 7, 2023

admin

Acclaimed Global CBD brand, Elixinol, is making a highly anticipated return to the UK market thanks to a partnership with BRITISH CANNABIS™.

This exciting development was made possible by the 2022 licensing and distribution agreement entered into with BRITISH CANNABIS™ a leading UK-based company.

With this strategic partnership in place, customers in the UK can look forward to experiencing the exceptional quality and purity of Elixinol’s CBD products, which have been meticulously crafted using the finest ingredients and industry-leading production techniques.

“As the trusted regional partner of Elixinol, we are thrilled to be able to bring you a range of cosmetics that not only enhances your skin’s natural radiance but also promotes overall well-being”, commented BRITISH CANNABIS™ Marketing Director, Steve Batchelor.

New partnership sees revamped ElixinolSkin cosmetics return to UK

Source link

Press Release EU ZA

CiiTECH Bought Out Of Administration By Fellow UK Company For £210,00

Published

6 months ago

April 7, 2023

admin

CBD company CiiTECH has been sold to fellow UK-based cannabis company Tenacious Labs for £210,000.

In July 2021 CiiTECH raised £2.1m to fund its listing on the London Stock Exchange with a slated value of £17.5m.

However, after two loss-making years it fell into administration on October 22, 2022, and on February 16, this year, it was sold to Tenacious Halfway – a subsidiary of Tenacious Labs – for £210,000.

Administrators Leonard Curtis said it had received 46 expressions of interest in buying the assets of the business, which resulted in five offers with Tenacious making the highest bid.

Nick Morland, CEO and co-founder of Tenacious Labs, told Business of Cannabis: “CiiTECH was in the same situation as a couple of dozen good businesses. The irony is that they got hit the hardest as they were busy on the next step (an LSE listing).

Source link